Rare HER2-positive mucinous cystadenocarcinoma of the breast

This breast cancer diagnosis at a glance

Biomarkers
HER2-positive; ER-negative; PR-negative
Sex
Female
Treatment
surgery and chemotherapy
Outcome
Care Ongoing

Treatment course, step by step

  1. She had a modified radical mastectomy.
  2. She then received systemic chemotherapy and was still on treatment 6 months later.

What happened, in summary

A 65-year-old woman sought care for a painful right breast lump with discharge that had been present for about a year. Imaging showed a very large breast mass, and chest imaging also raised concern for possible spread to the lungs. A biopsy initially suggested invasive ductal carcinoma with mucin.

She underwent a modified radical mastectomy. Examination of the surgical specimen showed an 18 cm tumor involving the breast and overlying skin. One of 15 axillary lymph nodes contained cancer. Further pathology and imaging supported a rare diagnosis of primary mucinous cystadenocarcinoma of the breast rather than a cancer that had spread to the breast from another organ.

The tumor was estrogen- and progesterone-receptor negative but HER2-positive. This HER2 result was confirmed with additional testing.

After surgery, she received systemic chemotherapy and was still on treatment 6 months later. Her treatment course remained ongoing at the latest documented point.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories